Government-Owned Inventions; Availability for Licensing, 46490 [06-6872-2]

Download as PDF 46490 Federal Register / Vol. 71, No. 156 / Monday, August 14, 2006 / Notices taper ensures higher damage threshold for the delivery waveguide in comparison to the conventional lens laser-to-fiber coupling. To improve the high-peak-power delivery capability of the proposed allow-hollow-waveguide DPIV illumination system, instead of a conventional solid-core fiber link, we have used a cyclic olefin polymer (COP)-coated hollow glass waveguide which is designed to minimize the waveguide attenuation losses at a typical DPIV laser wavelength of 532nm. This waveguide provides a significantly higher laser power delivery capability and higher damage threshold. The all-hollow-waveguide DPIV laser delivery system offers essential advanced features over conventional bulk-optics-based delivery techniques in terms of formatting thin (0.5–1.0 mm), wide (10 mm or wider) and uniform laser illumination sheet; high-peakpower laser delivery without damaging effects (> 1 GW/cm2), flexibility, miniaturization, simplified alignment, immunity to external influence (including vibrations and angular laser beam drift), and safe and confined laser delivery. Applications 2. Optics; Particle imaging: Velocimetry. jlentini on PROD1PC65 with NOTICES Collaborative Research Opportunity The Food and Drug Administration’s Center for Devices and Radiological Health is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. Please contact the inventors at 301/827–4685 for more information. Dated: July 28, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer; Office of Technology Transfer, National Institutes of Health. [FR Doc. 06–6873 Filed 8–11–06; 8:45 am] National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: Publications 1. IK Ilev et al., ‘‘Grazing-IncidenceBased Hollow Taper for Infrared Laserto-Fiber Coupling,’’ Applied Physics Letters, Vol. 74, 1999, pp. 2921–2923. 2. IK Ilev et al., ‘‘Uncoated Hollow Taper as a Single Optical Funnel for Laser Delivery,’’ Review of Scientific Instruments, Vol. 70, 1999, pp. 3840– 3843. 3. IK Ilev et al., ‘‘Ultraviolet Laser Delivery Using an Uncoated Hollow Taper,’’ IEEE Journal of Quantum Electronics, Vol. 36, 2000, pp. 944–948. 4. IK Ilev et al., ‘‘Attenuation Measurement of Infrared Optical Fibers Using a Hollow-Taper-Based Coupling Method,’’ Applied Optics, Vol. 39, 2000, pp. 3192–3196. 5. RA Robinson et al., ‘‘Design and Optimization of a Flexible High-Peak Power Laser-to-Fiber Coupled Illumination System Used in Digital Particle Image Velocimetry’’, Review of Scientific Instruments, Vol. 75, 2004, pp. 4856–4862. Jkt 208001 Licensing Contact Michael A. Shmilovich, Esq.; 301/ 435–5019. shmilovm.@mail.nih.gov. <mailto:shmilovm@mail.nih.gov.> DEPARTMENT OF HEALTH AND HUMAN SERVICES Inventors 6. Ilko K. Ilev, Ronald A. Robinson, Ronald W. Waynant (FDA). 17:58 Aug 11, 2006 Licensing Status 10. Available for non-exclusive or exclusive licensing. BILLING CODE 4140–01–M Market 4. Illumination, high peak laser powered delivery. VerDate Aug<31>2005 Patent Status 8. U.S. Provisional Application No. 60/730,866 filed 28 Oct 2005 (HHS Reference No. AE–015–2006/0–US–01). The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. SUMMARY: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 Model Th1 Clone Producing IFNgamma and IL–2 Description of Technology Available for licensing is the A.E7 T cell clone, a model Th1 clone described in Matis et al., J Immunol. 1983 Apr 130(4):1527–1535 [PubMed abs] and J Immunol. 1983 Sept 131(3):1049–1055 [PubMed abs]. This clone has been further utilized as a model for studying T cell clonal anergy. Potential Applications of Technology 2. Model Th1 clone capable of making IFN-gamma and IL–2 4. Model T cell clone for studying T cell clonal anergy Inventors Ronald H. Schwartz et al. (NIAID). Louis A. Matis (NIAID). Dan L. Longo (NCI). Toby T. Hecht (NCI). Patent Status HHS Reference No. E–214–2006/0— Research Tool. Licensing Status Available for non-exclusive licensing. Licensing Contact Susan Ano, Ph.D.; Phone: (301) 435– 5515; Email: anos@mail.nih.gov. Dated: July 31, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 06–6874 Filed 8–11–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditions commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 71, Number 156 (Monday, August 14, 2006)]
[Notices]
[Page 46490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federally-funded research and development. Foreign patent 
applications are filed on selected inventions to extend market coverage 
for companies and may also be available for licensing.

ADDRESSES: Licensing information and copies of the U.S. patent 
applications listed below may be obtained by writing to the indicated 
licensing contact at the Office of Technology Transfer, National 
Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, 
Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A 
signed Confidential Disclosure Agreement will be required to receive 
copies of the patent applications.

Model Th1 Clone Producing IFN-gamma and IL-2

Description of Technology

    Available for licensing is the A.E7 T cell clone, a model Th1 clone 
described in Matis et al., J Immunol. 1983 Apr 130(4):1527-1535 [PubMed 
abs] and J Immunol. 1983 Sept 131(3):1049-1055 [PubMed abs]. This clone 
has been further utilized as a model for studying T cell clonal anergy.

Potential Applications of Technology

    2. Model Th1 clone capable of making IFN-gamma and IL-2
    4. Model T cell clone for studying T cell clonal anergy

Inventors

Ronald H. Schwartz et al. (NIAID).
Louis A. Matis (NIAID).
Dan L. Longo (NCI).
Toby T. Hecht (NCI).

Patent Status

    HHS Reference No. E-214-2006/0--Research Tool.

Licensing Status

    Available for non-exclusive licensing.

Licensing Contact

    Susan Ano, Ph.D.; Phone: (301) 435-5515; Email: anos@mail.nih.gov.

    Dated: July 31, 2006.
Steven M. Ferguson,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer, National Institutes of Health.
[FR Doc. 06-6872 Filed 8-11-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.